OBJECTIVE: Anxiety and depression can substantially impact the life of a cancer patient, but literature on emotional distress in the Hispanic cancer population is sparse. Additionally, the influence of psychosocial variables including age, acculturation, and spiritual well-being on emotional distress in this population remains unclear. The purpose of the present report was to assess the prevalence of anxiety and depression in Spanish-speaking Latina cancer patients preparing to begin chemotherapy and to explore the predictors and correlates of these outcomes. METHODS: Participants were 198 Spanish-speaking Latina cancer patients who completed measures of anxiety, depression, acculturation, and spiritual well-being prior to starting chemotherapy. RESULTS: Prevalence of clinically significant anxious symptomatology was 52%, and prevalence of clinically significant depressive symptomatology was 27%. Longer time since diagnosis and less acculturation predicted more severe anxiety, while longer time since diagnosis, less acculturation, and older age predicted more severe depression (Ps < .05). In multivariable analyses, only time since diagnosis emerged as a significant predictor of anxiety and depression when accounting for the influence of other variables. Greater spiritual well-being was correlated with both less severe anxiety and less severe depression (Ps < .001). CONCLUSIONS: The present findings document the high prevalence of emotional distress, particularly anxiety, in this patient population prior to chemotherapy initiation and identify several demographic and clinical factors associated with increased risk for heightened distress. Additionally, these findings suggest that interventions to address distress in this patient population would benefit from including components that seek to improve patients' spiritual well-being.
OBJECTIVE:Anxiety and depression can substantially impact the life of a cancerpatient, but literature on emotional distress in the Hispanic cancer population is sparse. Additionally, the influence of psychosocial variables including age, acculturation, and spiritual well-being on emotional distress in this population remains unclear. The purpose of the present report was to assess the prevalence of anxiety and depression in Spanish-speaking Latina cancerpatients preparing to begin chemotherapy and to explore the predictors and correlates of these outcomes. METHODS:Participants were 198 Spanish-speaking Latina cancerpatients who completed measures of anxiety, depression, acculturation, and spiritual well-being prior to starting chemotherapy. RESULTS: Prevalence of clinically significant anxious symptomatology was 52%, and prevalence of clinically significant depressive symptomatology was 27%. Longer time since diagnosis and less acculturation predicted more severe anxiety, while longer time since diagnosis, less acculturation, and older age predicted more severe depression (Ps < .05). In multivariable analyses, only time since diagnosis emerged as a significant predictor of anxiety and depression when accounting for the influence of other variables. Greater spiritual well-being was correlated with both less severe anxiety and less severe depression (Ps < .001). CONCLUSIONS: The present findings document the high prevalence of emotional distress, particularly anxiety, in this patient population prior to chemotherapy initiation and identify several demographic and clinical factors associated with increased risk for heightened distress. Additionally, these findings suggest that interventions to address distress in this patient population would benefit from including components that seek to improve patients' spiritual well-being.
Authors: Barbara L Andersen; Charles L Shapiro; William B Farrar; Timothy Crespin; Sharla Wells-Digregorio Journal: Cancer Date: 2005-10-01 Impact factor: 6.860
Authors: Marielena Lara; Cristina Gamboa; M Iya Kahramanian; Leo S Morales; David E Hayes Bautista Journal: Annu Rev Public Health Date: 2005 Impact factor: 21.870
Authors: P Jimenez-Fonseca; C Calderón; R Hernández; T Ramón Y Cajal; M Mut; A Ramchandani; O Donnay; A Carmona-Bayonas Journal: Clin Transl Oncol Date: 2018-04-12 Impact factor: 3.405
Authors: Sarah E Piombo; Kimberly A Miller; Kaitlin Alderete; Alden Egan; Sally Golingay; Thomas W Valente Journal: J Cancer Educ Date: 2021-08 Impact factor: 2.037
Authors: Kelly A Hyland; Aasha I Hoogland; Brian D Gonzalez; Ashley M Nelson; Suzanne Lechner; Dinorah Martinez Tyson; Anna Barata; Maria F Gomez; Michael H Antoni; Brent Small; Cathy D Meade; Paul B Jacobsen; Heather S L Jim Journal: J Pain Symptom Manage Date: 2019-05-20 Impact factor: 3.612
Authors: Aasha I Hoogland; Suzanne C Lechner; Brian D Gonzalez; Brent J Small; Dinorah M Tyson; Yasmin Asvat; Anna Barata; Maria F Gomez; Yvelise Rodriguez; Heather S L Jim; Michael H Antoni; Paul B Jacobsen; Cathy D Meade Journal: Psychooncology Date: 2018-03-24 Impact factor: 3.894
Authors: Liliana Chacón; Jasmine Santoyo-Olsson; Cathy Samayoa; Alia Alhomsi; Anita L Stewart; Carmen Ortiz; Cristian Escalera; Anna María Nápoles Journal: Health Equity Date: 2021-04-26
Authors: Eida M Castro-Figueroa; Normarie Torres-Blasco; Milagros C Rosal; Julio C Jiménez; Wallesca P Castro-Rodríguez; Marilis González-Lorenzo; Héctor Vélez-Cortés; Alia Toro-Bahamonde; Rosario Costas-Muñiz; Guillermo N Armaiz-Peña; Heather Jim Journal: Nurs Rep Date: 2021-06-09
Authors: Diva Cristina Morett Romano Leão; Eliane Ramos Pereira; María Nieves Pérez-Marfil; Rose Mary Costa Rosa Andrade Silva; Angelo Braga Mendonça; Renata Carla Nencetti Pereira Rocha; María Paz García-Caro Journal: Int J Environ Res Public Health Date: 2021-06-13 Impact factor: 3.390